GKSL to Acquire 100% Stake in Parekhs Hospital for ₹77 Crore
Gujarat Kidney And Super Speciality Limited will acquire 100% equity in Parekhs Hospital Private Limited for ₹77 crore. This acquisition is expected to be completed in approximately 2 months and aims to strengthen GKSL's healthcare sector presence and diversify its business portfolio.
Acquiring a company in full, especially a healthcare provider, is a material event that can significantly alter the company's market position, revenue, and operational scale.
The acquisition of a 100% stake in another hospital is a significant expansion for GKSL, indicating growth and strategic intent, which is viewed positively.
Gujarat Kidney And Super Speciality Limited (GKSL) announced today, January 2nd, 2026, that its Board of Directors has approved the acquisition of a 100% equity stake in Parekhs Hospital Private Limited. This strategic move aims to make Parekhs Hospital a wholly-owned subsidiary of GKSL.
The acquisition is expected to strengthen GKSL's presence in the healthcare sector and diversify its business portfolio. Parekhs Hospital Private Limited, incorporated in 2006 and based in Ahmedabad, Gujarat, is a medical and healthcare service provider. Its authorized share capital is ₹85,00,000 and paid-up capital is ₹25,50,000. For the financial year 2024-25, Parekhs Hospital reported a turnover of ₹25,66,69,000. The company's turnover for the previous two financial years was ₹26,35,59,000 (FY 2023-24) and ₹24,08,44,000 (FY 2022-23).
The total consideration for the acquisition is ₹77,00,00,000 (seventy-seven crore rupees) in cash. The indicative time period for the completion of this acquisition is approximately 2 months. The Board meeting commenced at 10:00 a.m. and concluded at 11:00 a.m. on January 2nd, 2026.
What to do with a filing like this
Gujarat Kidney And Super Speciality Limited filed this with the NSE as a statutory disclosure, categorised under acquisition. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Gujarat Kidney And Super Speciality Limited. Read the original for the full detail.